Your browser doesn't support javascript.
loading
Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension.
Wilding, John P H; Batterham, Rachel L; Davies, Melanie; Van Gaal, Luc F; Kandler, Kristian; Konakli, Katerina; Lingvay, Ildiko; McGowan, Barbara M; Oral, Tugce Kalayci; Rosenstock, Julio; Wadden, Thomas A; Wharton, Sean; Yokote, Koutaro; Kushner, Robert F.
Affiliation
  • Wilding JPH; Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.
  • Batterham RL; University College London Centre for Obesity Research, Division of Medicine, University College London, London, UK.
  • Davies M; National Institute of Health Research, UCLH Biomedical Research Centre, London, UK.
  • Van Gaal LF; Centre for Weight Management and Metabolic Surgery, University College London Hospital, London, UK.
  • Kandler K; Diabetes Research Centre, University of Leicester, Leicester, UK.
  • Konakli K; NIHR Leicester Biomedical Research Centre, Leicester, UK.
  • Lingvay I; Department of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
  • McGowan BM; Novo Nordisk A/S, Søborg, Denmark.
  • Oral TK; Novo Nordisk A/S, Søborg, Denmark.
  • Rosenstock J; Departments of Internal Medicine/Endocrinology and Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Wadden TA; Department of Diabetes and Endocrinology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Wharton S; Novo Nordisk A/S, Søborg, Denmark.
  • Yokote K; Dallas Diabetes Research Center at Medical City, Dallas, Texas, USA.
  • Kushner RF; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Diabetes Obes Metab ; 24(8): 1553-1564, 2022 08.
Article in En | MEDLINE | ID: mdl-35441470

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Weight Gain / Glucagon-Like Peptides Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Weight Gain / Glucagon-Like Peptides Type of study: Clinical_trials / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2022 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom